VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Bonne Chance

<< Previous

Bullboard Posts

Next >>

Comment by JohnPhilipon Dec 17, 2023 9:27am

105 Views

Post# 35788686

RE:RE:RE:RE:RE:RE:Bonne Chance

it would be helpfull for investors to hear from people who have used the technology. Nurses technicians Doctors and patients. Possibly in the future Ventripoint and Ascend will find time to share that information. Another good reason for Ventripoint to be linked to colaberate with the Ollie Heinkel Society.

The concept of the technolgy is a game changer.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale